Asian Pacific Association for the Study of the Liver
Single Topic Conference
Focus on the Virus Hepatitis B
3-6 October 2015 Yerevan, Armenia
Home page

Scientific Program at a Glance

Saturday, October3

 Social Program

12:00-17:00

Registration

Sunday, October 4

 

09:00–09:15

Opening Ceremony

09:15–11:55

Session 1 – HBV: Overview of Epidemiology and Burden of Disease

Chairs: Ara  Asoyan , Sang Hoon Ahn, Gayane   Melik-Andreasyan,  Osuma Yokosukao,   Tsaxik Vardanyan

09:15–09:30

The Changing Epidemiology of HBV in Asia

Sang Hoon Ahn, South Korea

09:30-09:45

The Changing Epidemiology of HBV in Mongolia

Oidov Baatarkhuu, Mongolia

09:45-10:00

The Changing Epidemiology of HBV in Europe

Pierre Van Damme, Belgium

10:00-10:15

The Changing Epidemiology of HBV in North America

Ray Kim, USA


10:15-11:55

Epidemiology of HBV Infection in CIS countries

10:15-10:25

Epidemiology of HBV Infection in Russia

Vladimir Chulanov, Russia

10:25-10:35

Epidemiology of HBV Infection in Ukraine

Larisa Moroz, Ukraine

10:35-10:45

Epidemiology of HBV Infection in Belarus

Igor Karpov, Belarus

10:45-10:55

Epidemiology of HBV Infection in Georgia

David Metreveli, Georgia

10:55-11:05

Epidemiology of HBV Infection in Moldova

Iuliana Lupasco, Moldova

11:05-11:15

Epidemiology of HBV Infection in Kazakhstan

Alexander Nersesov, Kazakhstan

11:15-11:35

Epidemiology of HBV Infection in Armenia

Hasmik Ghazinyan, Gayane Melik-Andreasyan,
Gayane Sahakyan, Armenia

11:35-11:55

Discussion

11:55-12:25

Coffee break


12:25-13:30

Session 2 - VIROLOGY AND IMMUNOPATHOGENESIS

Chairs:Richard  Moreau, Tigran Davtyan, Robert Gish, Irakli Rtskhiladze ,                      Ara Babloyan

 

12:25-12:40

Covalently Closeed Circular (ccc) DNA is the only reason,
unable clear HBV; May need Immunological Atttack?

Masao Omata, Japan

12:40-12:55

HBV Genotypes and Core and Pre-core Mutations

Robert G Gish, USA

12:55-13:10

Interactions Between HBV, Host Immunity and the liver

Tigran Davtyan, Armenia

13:10-13:30

Discussion

13:30-14:30

Lunch


 

14:30-16:30

Session 3 - NATURAL HISTORY

Chairs: Massao Omata, Oidov Baatarkhuu, Narine Pashinyan, David Metreveli,         Ray Kim

 

14:30-14:45

Natural History of Chronic Hepatitis B and
Predictors of Disease Progression (viral and host)

Diana A.Payawal, Philippines

14:45-15:00

Occult HBV Infection: Clinical Significance

Saeed Hamid, Pakistan

15:00-15:15

HBV - HCC

Kim Ray, USA

15:15-15:30

Discussion

15:30-15:50

Acute - on - Chronic liver failure (ACLF)

Shiv Kumar Sarin, India

15:50-16:05

HBV - ACLF

Richard Moreau, France

16:05-16:20

The Role of Non-invasive Markers and Imaging in
Staging liver Disease in Chronic HBV Infection

Salimur Rahman, Bangladesh

16:20-16:30

Discussion

16:30-17:00

Coffee Break


17:00-18:00

SESSION 4 - TREATMENT INDICATIONS AND OPTIONS

Chairs:Hasmik Ghazinyan, Diana A. Payawal, Larisa Moroz ,Vladimir Chulanov,     Gamal Shiha

 

17:00-17:20

HBV: Treatment Indications and Therapeutic End-points

Shiv Kumar Sarin, India

17:20-17:40

Is Clearance of HBsAg and cccDNA a Realistic Target?

 

Robert G. Gish, USA

17:40-17:55

Discussion

17:55-18:00

First Day Closing

Faculty Dinner including Social Program

Program is subject to change


Monday, October 5 2015

 

09:00-11:00

SESSION 5 - CURRENT TREATMENT FOR CHB

Chairs:Manoj Kumar Sharma, Pierre Bedossa, Saeed Hamid, Igor Karpov,         Violeta Sargsyan

 

09:00-09:15

Treatment of Patients with CHB with Pegylated Interferon: Clinical Significance of HBV DNA and HBsAg Quantitative Testing

Alaaeldin Ibrahim, Egypt

09:15-09:30

NAs as First-line Therapy for CHB

Gamal Shiha, Egypt

09:30-09:45

Monitoring and Management of NAs failures

Vladimir Chulanov, Russia

09:45-10:00

Risk factors of HCC during nucleic acid
treatment on chronic hepatitis B

Osamu Yokosuka, Japan

10:00-10:20

Management of CHB patients with Decompensated Cirrhosis

Chay Dai, Taiwan

10:20-10:40

Can Cirrhosis be Really Reversed? A focus on the Parenchymal Extinction Nodule

Pierre Bedossa, France

10:40-11:00

Discussion

11:00-11:30

Coffee Break


11:30-13:30

SESSION 6 - CHB in SPECIAL POPULATIONS

Chairs:Barjesh Sharma, Mamun –Al-Mahtab ,  Gagik Hakopyan, Luliana Lupasco ,   Chia –Yen Dai

 

11:30-11:50

Management of CHB in the Immunosuppressed Patients

Narina Sargsyants, Armenia

11:50-12:10

Management of CHB in Children

Mamun- AL- Mahtab, Bangladesh

12:10-12:30

Management of CHB in Pregnancy

Hasmik Ghazinyan, Armenia

12:30-12:50

Management of CHB in Co-infected Patients (HBV - HCV ),
and (HBV - HIV )

Violeta Sargsyan, Armenia

12:50-13:10

Management of CHB in Renal Disease and Renal
Failure Patients

Barjesh Sharma, India

13:10-13:30

Discussion

13:30-14:30

Lunch


14:30-16:00

SESSION 7 – INTERACTIVE CASE STUDY DISCUSSIONS
ON THE TREATMENT OF CHB (DIFFICULT- TO- TREAT CASE
SCENARIOS) AND WHO-POLICY

Chairs: Robert G. Gish, Narina Sargsyants, Antons Mozalevskis, Alexander Nersesov, Aregnaz Mkhitaryan

 

14:30-14:45

Case 1.

Case-Based_Management HBV reactivation

Robert Gish, USA

14:45-15:00

Case 2.

UNUSUAL CASE OF HIGHLY REPLICATIVE HBV VIRUS
INFECTION WITH EXTRAHEPATIC MANIFESTATIONS

Narina Sargsyants, Armenia

15:00-15:15

Hepatitis B reactivation after pagylated interferon
plus ribavirin in chronic HBV/HCV coinfected
Taiwanese patient

Chia-Yen Dai, Taiwan

15:15-15:30

Case of HBV related chronic liver disease presenting
as acute hepatitis

Mamun- AL- Mahtab, Bangladesh 

15:30-15:45


Managment of chronic Hepatitis D

Alexander Nersesov, Kazakhstan

15:45-16:05

WHO - Policy

Antons Mozalevskis, WHO

15:05-16:15

Discussion


16:15-18:00

SESSION 8 - WHAT IS ON THE HORISON FOR
TREATMENT OF CHB? NEW TARGETS FOR HBV

Chairs: Gerardo Enrique Guilleen,  Pavel Bogomolov,  Salimur Rahman,                Alaaeldin Ibrahim, Hasmik Ghazinyan 

 

16:15-16:35

Treatment of HBV Beyond the Guidelines

Manoj Kumar Sharma, India

16:35-16:55

Other New Therapies

Robert G Gish, USA

16:55-17:10

Myrcludex B, an NTCP- specific Inhibitor of HBV
and HDV Entry

Pavel Bogomolov, Russia

17:10-17:20

Immune Based Therapies for CHB

Gerardo Enrique Guilleen, Cuba

17:20-17:40

Discussion

17:40-18:00

Meeting Closing

Gala Dinner Including Social Program

Program is subject to change

October 6, 2015

17:00-19:00

Satellite Symposium

Roche

 


  • ASIAN PACIFIC ASSOCIATION FOR STUDY OF THE LIVER